Empyrean Capital Partners, LP
Investment Portfolio & 13F Holdings Analysis
About
Empyrean Capital Partners, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 59 holdings worth $2.8 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "AGI.TO", "FTAI", "AKAM", null, "PCG", "SABR", null, "MAGN", null, "ALIT", "APG", "ATUS", "LLYVA", "NMRK", "FG", "SWTX", "TDS", null, null, "AMBP", null, null, "FIP", null, "SARO", null, null, "MPC", null, null, "HES", "AER", null, "UNH", "SPY", "NN", "SHEL", "NG", "SBGI", null, null, "BENFW", "CAH", "ENVA", "SIRI", "VAL", null, "HNRG", "AEM", null, "LBRDK", "LLYVK", null, "NGD", "VTOL", "BUR", "CVS", "DFS", "IWM" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 59
- Total Value
- 2815473081
- Accession Number
- 0001085146-25-003352
- Form Type
- 13F-HR
- Manager Name
- Empyrean-Capital-Partners-Lp
Data Enrichment
69% identified41 identified18 unidentified
Holdings
59 positions • $2.8B total value
Manager:
Search and click to pin securities to the top
Page 1 of 3
464288513
Shares:5.8M
Value:$457.6M
% of Portfolio:16.3% ($457.6M/$2.8B)
69349H107
Shares:1.4M
Value:$75.1M
% of Portfolio:2.7% ($75.1M/$2.8B)
10948W103
Shares:1.9M
Value:$48.6M
% of Portfolio:1.7% ($48.6M/$2.8B)
69553PAD2
Shares:—
Value:$39.6M
% of Portfolio:1.4% ($39.6M/$2.8B)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
(cusip464288513)✕ | 5.8M | QoQ NEW(+5.8M) YoY NEW(+5.8M) | All Managers (Combined) | $457.6M | 16.3% ($457.6M/$2.8B) | QoQ NEW(+$457.6M) YoY NEW(+$457.6M) |
1.8M | All Managers (Combined) | $366.1M | 13.0% ($366.1M/$2.8B) | |||
1.2M | All Managers (Combined) | $191.5M | 6.8% ($191.5M/$2.8B) | |||
2.3M | QoQ 0.00% (+0)YoY NEW(+2.3M) | All Managers (Combined) | $168.5M | 6.0% ($168.5M/$2.8B) | YoY NEW(+$168.5M) | |
1.4M | All Managers (Combined) | $141.2M | 5.0% ($141.2M/$2.8B) | |||
220.0K | QoQ NEW(+220.0K) YoY NEW(+220.0K) | All Managers (Combined) | $123.1M | 4.4% ($123.1M/$2.8B) | QoQ NEW(+$123.1M) YoY NEW(+$123.1M) | |
CVS HEALTH Corp(CVScusip126650100) | 1.5M | YoY NEW(+1.5M) | All Managers (Combined) | $103.7M | 3.7% ($103.7M/$2.8B) | YoY NEW(+$103.7M) |
520.5K | QoQ NEW(+520.5K) | All Managers (Combined) | $75.8M | 2.7% ($75.8M/$2.8B) | QoQ NEW(+$75.8M) | |
(cusip69349H107)✕ | 1.4M | All Managers (Combined) | $75.1M | 2.7% ($75.1M/$2.8B) | ||
3.8M | All Managers (Combined) | $65.3M | 2.3% ($65.3M/$2.8B) | |||
APi Group Corp(APGcusip00187Y100) | 1.8M | All Managers (Combined) | $64.4M | 2.3% ($64.4M/$2.8B) | ||
120.0K | QoQ NEW(+120.0K) YoY NEW(+120.0K) | All Managers (Combined) | $62.9M | 2.2% ($62.9M/$2.8B) | QoQ NEW(+$62.9M) YoY NEW(+$62.9M) | |
554.3K | QoQ NEW(+554.3K) YoY NEW(+554.3K) | All Managers (Combined) | $61.5M | 2.2% ($61.5M/$2.8B) | QoQ NEW(+$61.5M) YoY NEW(+$61.5M) | |
20.1M | YoY NEW(+20.1M) | All Managers (Combined) | $53.5M | 1.9% ($53.5M/$2.8B) | YoY NEW(+$53.5M) | |
4.4M | All Managers (Combined) | $53.1M | 1.9% ($53.1M/$2.8B) | |||
379.0K | QoQ NEW(+379.0K) YoY NEW(+379.0K) | All Managers (Combined) | $52.2M | 1.9% ($52.2M/$2.8B) | QoQ NEW(+$52.2M) YoY NEW(+$52.2M) | |
512.8K | All Managers (Combined) | $49.5M | 1.8% ($49.5M/$2.8B) | |||
(cusip10948W103)✕ | 1.9M | All Managers (Combined) | $48.6M | 1.7% ($48.6M/$2.8B) | ||
7.5M | All Managers (Combined) | $44.5M | 1.6% ($44.5M/$2.8B) | |||
(cusip69553PAD2)✕ | — | QoQ - YoY NEW | All Managers (Combined) | $39.6M | 1.4% ($39.6M/$2.8B) | YoY NEW(+$39.6M) |